• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Comparison of acute pneumonia caused by SARS-COV-2 and other respiratory viruses in children: a retrospective multi-center cohort study during COVID-19 outbreak
ConclusionThe symptoms and severity of COVID-19 pneumonia in children were no more severe than those in children with other viral pneumonia. Lopinavir-ritonavir, ribavirin and arbidol do not shorten the duration of positive PCR results from pharyngeal swabs in children with COVID-19. During the COVID-19 outbreak, attention also must be given to children with infection by other pathogens infection.
Source: Military Medical Research - February 16, 2021 Category: International Medicine & Public Health Source Type: research

Chemoprophylaxis, diagnosis, treatments, and discharge management of COVID-19: An evidence-based clinical practice guideline (updated version)
AbstractThe novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, coronavirus disease 2019 (COVID-19), affecting more than seventeen million people around the world. Diagnosis and treatment guidelines for clinicians caring for patients are needed. In the early stage, we have issued “A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)”; now there are many direct evidences emerged and may change some of previous recommendations and it is ripe for develop an evidence-based guideline. W...
Source: Military Medical Research - September 3, 2020 Category: International Medicine & Public Health Source Type: research

The Curious Case of Covid-19 in Africa
Eunice G. Kamwendo is an Economist and Strategic Advisor with UNDP Africa in New York. Chaltu Daniel Kalbessa is a UNDP Fellow and Strategic Analyst with UNDP Africa in New York.By Eunice G. Kamwendo and Chaltu Daniel KalbessaNEW YORK, Jun 3 2020 (IPS) With very weak health systems and overall capacity constraints to effectively respond to the deadly coronavirus disease, Africa’s fate against the invisible enemy, was going to be nothing short of catastrophic according to early predictions. Although Africa is yet to reach its peak, many countries are not seeing the exponential growth in case numbers, or in mortality rates...
Source: IPS Inter Press Service - Health - June 3, 2020 Category: International Medicine & Public Health Authors: Eunice G. Kamwendo and Chaltu Daniel Kalbessa Tags: Africa Aid Headlines Health Humanitarian Emergencies TerraViva United Nations Source Type: news

Clinical trials on drug repositioning for COVID-19 treatment.
Authors: Rosa SGV, Santos WC Abstract The World Health Organization (WHO) was informed on December 2019 about a coronavirus pneumonia outbreak in Wuhan, Hubei province (China). Subsequently, on March 12, 2020, 125,048 cases and 4,614 deaths were reported. Coronavirus is an enveloped RNA virus, from the genus Betacoronavirus, that is distributed in birds, humans, and other mammals. WHO has named the novel coronavirus disease as COVID-19. More than 80 clinical trials have been launched to test coronavirus treatment, including some drug repurposing or repositioning for COVID-19. Hence, we performed a search in March 2...
Source: Pan American Journal of Public Health - April 9, 2020 Category: International Medicine & Public Health Tags: Rev Panam Salud Publica Source Type: research